Insights from JP Morgan Healthcare 2025: Key trends shaping the pharma industry

The JP Morgan Healthcare Conference remains one of the most influential events for the life sciences sector, setting the stage for major deal-making, investment trends, and strategic shifts that will define the year ahead.

Keen to capture all the key trends and talking points from this year’s event, pharmaphorum editor-in-chief, Jonah Comstock, hit the ground running in Philadelphia, live blogging key sessions and interviewing experts to find out what industry insiders foresee for 2025.

In this special extended episode of the pharmaphorum podcast, Jonah sits down with Deep Dive editor, Eloise McLennan, to break down the key themes and takeaways from this year’s event.

From the impact of the new Trump Administration on research and development to advancements in brain health, PBM reform, and the evolving role of GenAI in clinical trials, they explore the discussions and developments set to shape pharma’s trajectory in 2025 and beyond.

Plus, hear exclusive interviews from experts, including:

• Catherine Owen Adams from Acadia Pharmaceuticals on trends and innovations in brain health
• NKarta’s Paul Hastings discusses natural killer cells and developments in cell and gene therapies
• Evidation’s Phil Johnson on the role of real world data in drug development
• Grove AI’s Tran Le and Sohit Gatiganti on the immense potential of AI in audio for clinical trials

You can listen to this episode, as well as previous episodes of the pharmaphorum podcast, in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, Amazon Music, Podbean, and pretty much wherever you get your other podcasts!